Cite
HARVARD Citation
Jang, D. et al. (2016). Cell‐based high‐throughput screening identifies galactocerebrosidase enhancers as potential small‐molecule therapies for Krabbe's disease. Journal of neuroscience research. 94 (11), pp. 1231-1245. [Online].